XML 26 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2018
Dec. 31, 2017
Jan. 01, 2017
Cash flows from operating activities:      
Net income $ 361,972 $ 277,905 $ 214,678
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 53,665 44,369 38,140
(Gain) loss on sale/disposal of assets (4,737) (3,148) 863
Amortization of debt issuance costs 8,033 10,976 6,418
(Benefit) provision for deferred income taxes (872) 6,160 (3,059)
Non-cash compensation expense 22,792 20,713 18,564
Excess tax benefits from equity-based compensation (23,786) (27,227) (48,129)
Provision (benefit) for losses and accounts and notes receivable 899 (277) (224)
Changes in operating assets and liabilities:      
Increase in accounts receivable (18,172) (22,649) (18,724)
(Increase) decrease in inventories, prepaid expenses and other (12,455) 1,527 (2,947)
Increase in accounts payable and accrued liabilities 10,010 22,267 78,929
Increase in insurance reserves 2,174 8,420 2,764
Changes in advertising fund assets and liabilities, restricted (5,352) 2,225 5,187
Net cash provided by operating activities 394,171 341,261 292,460
Cash flows from investing activities:      
Capital expenditures (119,888) (90,011) (58,555)
Proceeds from sale of assets 8,367 6,835 4,936
Maturities of advertising fund investments, restricted 94,007 0 0
Purchases of advertising fund investments, restricted (70,152) 0 0
Other (591) (562) (1,661)
Net cash used in investing activities (88,257) (83,738) (55,280)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 970,000 1,900,000 63,000
Repayments of long-term debt and capital lease obligations (604,088) (928,193) (122,334)
Proceeds from exercise of stock options 9,832 6,099 15,234
Excess tax benefits from equity-based compensation 0 0 48,129
Purchases of common stock (591,212) (1,064,253) (300,250)
Tax payments for restricted stock upon vesting (6,962) (9,449) (5,646)
Payments of common stock dividends and equivalents (92,166) (84,298) (73,925)
Cash paid for financing costs (8,207) (16,846)  
Other 0 (205) 0
Net cash used in financing activities (322,803) (197,145) (375,792)
Effect of exchange rate changes on cash (538) 66 (1,279)
Change in cash and cash equivalents, restricted cash and cash equivalents (17,427) 60,444 (139,891)
Cash and cash equivalents, beginning of period 35,768 42,815 133,449
Restricted cash and cash equivalents, beginning of period 191,762 126,496 180,940
Cash and cash equivalents included in advertising fund assets, restricted, beginning of period 27,316 25,091 19,904
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, beginning of period 254,846 194,402 334,293
Cash and cash equivalents, end of period 25,438 35,768 42,815
Restricted cash and cash equivalents, end of period 166,993 191,762 126,496
Cash and cash equivalents included in advertising fund assets, restricted, end of period 44,988 27,316 25,091
Cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, end of period $ 237,419 $ 254,846 $ 194,402